Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 23, 2017
SillaJen has entered into a CRADA with the National Cancer Institute for the development of a combination therapy for colorectal cancer.
read more
Friday, February 21, 2020
Sihuan announced Xuanzhu Biopharmaceutical acquired all interests and intellectual property rights of plazomicin.
read more
Signature Biologics, LLC., announced their expanded operations footprint to include a new 36,000 sq ft facility in Irving, TX. This newly constructed space mirrors Signature Biologics' transparency in doing business with open floor plan and floor-to-...
read more
Signant Health will provide expert insights at the forthcoming DIA Global Annual Meeting in San Diego, CA June 23-27, 2019.
read more
Tuesday, February 18, 2020
Signant Health has opened a new office facility in Blue Bell, Pennsylvania. Construction on the new office, which is the largest workplace in Signant Health’s global network, completed in February 2020.
read more
Signant Health has announced the appointment of Roger Smith as Chief Executive Officer.
read more
Wednesday, November 27, 2019
Signant Health announced has joined the non-profit Association of Clinical Research Organizations (ACRO).
read more
Wednesday, January 29, 2020
Signant Health has announced new audit trail reviewing and reporting functionality today for its electronic clinical outcome assessment (eCOA) and remote sensor platform, TrialMax®.
read more
Thursday, September 12, 2019
Signant Health has been selected to provide electronic informed consent for a significant neuroscience study by the prestigious Shanghai Mental Health Center.
read more
Tuesday, January 07, 2020
Signant Health announced a partnership to connect TrialMax to Propeller Health’s digital health platform for asthma and COPD.
read more
CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, launched as Signant Health.
read more
Wednesday, February 12, 2020
The SCOPE Summit for Clinical Operations Executives has announced their event lectures.
read more
Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer.
read more
Wednesday, March 25, 2020
Signals Analytics has unveiled its COVID-19 Playbook, providing access to critical market intelligence and trends surrounding potential treatments for the novel coronavirus.
read more
SignalChem Lifesciences announces a collaboration with Merck to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer.
read more